Flying Eze and its trusted partners need your
permission to store and access cookies, unique identifiers, personal data, and information on your
browsing behaviour on this device. This only applies to Flying Eze. You don’t have to accept, and
you
can change your preferences at any time via the Privacy Options link at the bottom of this screen. If
you don’t accept, you may will still see some personalised ads and content.
Cookies, device identifiers, or other information can be stored or accessed on
your device for the purposes presented to you.
Ads and content can be personalised based on a profile. More data can be added
to better personalise ads and content. Ad and content performance can be
measured. Insights about audiences who saw the ads and content can be derived.
Data can be used to build or improve user experience, systems and software.
Precise geolocation and information about device characteristics can be used.
If you don’t want to accept, please select Read More option below where you can also see how and
why your data may be used. You can also see where we or our partners claim a legitimate interest and
object to the processing of your data.
India reported more than 350,000 new COVID-19 cases along with 2,800 deaths on Monday, and there are concerns with some experts saying the numbers coming out of the South Asian country are likely an undercount.
Mission B.C.’s Harminder Gill, like many members of Canada’s Indian diaspora, said he is very concerned about the situation in India and fears for family members who live there.
“[I’m] very concerned for the reason that I don’t think they have access to Medicare like we do,”he said.
World Health Organization chief Tedros Adhanom Ghebreyesus called the situation in India “beyond heartbreaking” on Monday. He added WHO would be sending extra staff and supplies there to help fight the pandemic.
Canada has also said it is ready to step in and supply India with medical and personal protective equipment.
The White House said the U.S. said it would make available sources of raw material urgently needed to manufacture Covishield, the Oxford-AstraZeneca vaccine made by the Serum Institute of India.
Satwinder Bains of the South Asian Studies Institute at the University of the Fraser Valley raises concerns about the reluctance of some to buy in and accept the threat posed by COVID-19.
“In a country like India where people are in rural cities, small villages, big cities — I am sure it is a very difficult task to get everyone to agree that these are the needs of the day and to follow through with them,” Bains said. “I think that is India’s biggest challenge.”